KADCEP

This brand name is authorized in Nigeria.

Active ingredients

The drug KADCEP contains one active pharmaceutical ingredient (API):

1	Cefpodoxime UNII 2TB00A1Z7N - CEFPODOXIME PROXETIL
	Like other beta-lactam drugs, cefpodoxime exerts antibacterial activity by binding to and inhibiting the action of certain bacterial cell wall synthetic enzymes, namely the penicillin binding proteins.
	Read more about Cefpodoxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100552	Tablet	KADCEP TAB 200 mg	KADCEP CEFPRODOXIME PROXETIL 20MG CEFPODOXIME PROXETIL 200MG Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 1X10 POM 1 27/09/2022 KADARK PHARMACEUTICALS LIMITED, 19 BORNU CRESENT, APAPA LAGOS 8028351780 kadarkpharmaceuticalsltd@gmail.com MIRAFLASH NIGERIA LIMITED, 2-8 SUCCESS ESTATE ,OFF BRENTFIELD AVENUE OKE AFA OMOTEDO, MAGBORO, OGUN STATE. , Nigeria	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD13	Cefpodoxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100552